RecruitingPhase 3NCT07174310
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Sponsor: Hoffmann-La Roche
Burlington, VT · +52 more sites
4 recruiting parkinson's disease studies with a site in Burlington, VT.
All trials in Burlington, VT · All Parkinson's Disease trials
Sponsor: Hoffmann-La Roche
Burlington, VT · +52 more sites
Sponsor: Bayer
Burlington, VT · +26 more sites
Sponsor: BlueRock Therapeutics
Burlington, VT · +33 more sites
Sponsor: University of Vermont Medical Center
Burlington, VT
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.